Patents by Inventor Barry M. Weichman

Barry M. Weichman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating pulmonary inflammation
    Patent number: 5080899
    Abstract: This invention provides a method of preventing or reversing pulmonary inflammation in a mammal by administering an effective amount of rapamycin orally, parenterally, intranasally, or intrabronchially. As such, rapamycin is useful in providing the symptomatic relief of diseases in which pulmonary inflammation is a component such as, asthma, chronic obstructive pulmonary disease, emphysema, acute respiratory distress syndrome, bronchitis, and the like.
    Type: Grant
    Filed: February 22, 1991
    Date of Patent: January 14, 1992
    Assignee: American Home Products Corporation
    Inventors: Robert J. Sturm, Laurel M. Adams, Barry M. Weichman
  • Imidazolylthioalkenoic acids and -alkenols and leukotriene antagonistic composition containing them
    Patent number: 4769386
    Abstract: The imidazolylthio substituted alkanoic acids represented by the formula (I) or (IA) as defined herein have been found to be leukotriene antagonists and useful in the treatment of diseases in which leukotrienes are a factor, such as asthma.
    Type: Grant
    Filed: October 24, 1986
    Date of Patent: September 6, 1988
    Assignee: Smithkline Beckman Corporation
    Inventors: William E. Bondinell, David T. Hill, Barry M. Weichman
  • Method of antagonizing the effects of thromboxane
    Patent number: 4536510
    Abstract: Methods of antagonizing the effects of thromboxane A.sub.2 in the circulatory system of an animal which comprises administering to said animal a nontoxic effective amount of N,N'-bis[7-(3-chlorobenzeneaminosulfonyl)-1,2,3,4-tetrahydroisoquinolyl]di sulfonylimide or a pharamaceutical acceptable salt thereof are valuable in the treatment of diseases in which thromboxane A.sub.2 is a factor, such as thrombosis, endotoxic shock and cardiac anaphylaxis.
    Type: Grant
    Filed: July 22, 1983
    Date of Patent: August 20, 1985
    Assignee: Smith Kline Beckman Corporation
    Inventors: Martin A. Wasserman, Barry M. Weichman